JP7336098B2 - Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable inkjet ink composition, composition container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image Forming method, cured product, and decorative body - Google Patents

Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable inkjet ink composition, composition container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image Forming method, cured product, and decorative body Download PDF

Info

Publication number
JP7336098B2
JP7336098B2 JP2019164371A JP2019164371A JP7336098B2 JP 7336098 B2 JP7336098 B2 JP 7336098B2 JP 2019164371 A JP2019164371 A JP 2019164371A JP 2019164371 A JP2019164371 A JP 2019164371A JP 7336098 B2 JP7336098 B2 JP 7336098B2
Authority
JP
Japan
Prior art keywords
active energy
energy ray
curable
dimensional
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019164371A
Other languages
Japanese (ja)
Other versions
JP2020169310A (en
Inventor
宗 野口
充展 森田
崇 岡田
竜輝 山口
晃二 有光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo University of Science
Ricoh Co Ltd
Original Assignee
Tokyo University of Science
Ricoh Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo University of Science, Ricoh Co Ltd filed Critical Tokyo University of Science
Priority to US16/837,153 priority Critical patent/US11920045B2/en
Publication of JP2020169310A publication Critical patent/JP2020169310A/en
Application granted granted Critical
Publication of JP7336098B2 publication Critical patent/JP7336098B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、活性エネルギー線硬化型組成物、活性エネルギー線硬化型インク組成物、活性エネルギー線硬化型インクジェット用インク組成物、組成物収容容器、2次元または3次元の像形成装置、2次元または3次元の像形成方法、硬化物、及び、加飾体に関する。 The present invention provides an active energy ray-curable composition, an active energy ray-curable ink composition, an active energy ray-curable inkjet ink composition, a composition container, a two-dimensional or three-dimensional image forming apparatus, a two-dimensional or It relates to a three-dimensional image forming method, a cured product, and a decorative body.

紙、プラスチック等の記録媒体上に画像を形成する方法として、インクジェット記録方式が知られている。この記録方式は、インクの消費効率が高く省資源性に優れており、単位記録当たりのインクコストを低く抑えることが可能である。
近年、紫外線硬化型インクを用いたインクジェット記録方式が注目されている。
An inkjet recording method is known as a method for forming an image on a recording medium such as paper or plastic. This recording method has high ink consumption efficiency and is excellent in resource saving, and it is possible to keep the ink cost per unit recording low.
2. Description of the Related Art In recent years, attention has been paid to an inkjet recording method using an ultraviolet curable ink.

特許文献1、2には、ビニルエーテル基及び(メタ)アクリレート基を含むモノマーと、フリーラジカル重合により硬化可能な五員環状無水物を含むモノマーと、脂肪族第3級アミンとを含有する、特にプリント基板製造における記銘(legend)印刷に適した放射線硬化性インキが開示されている。 Patent Documents 1 and 2 disclose a monomer containing a vinyl ether group and a (meth)acrylate group, a monomer containing a five-membered cyclic anhydride curable by free radical polymerization, and an aliphatic tertiary amine, especially Radiation curable inks suitable for legend printing in printed circuit board manufacturing are disclosed.

特許文献3には、a)アクリレート基と、ビニルエーテル基、アリルエーテル基及びアリルエステル基より成る群から選ばれる第2のエチレン性不飽和重合可能官能基とを有する重合可能化合物Aと、b)二官能性アクリレートからなる重合可能化合物Bと、c)トリアクリレート、テトラアクリレート、ペンタアクリレート及びヘキサアクリレートより成る群から選ばれる重合可能化合物Cと、を含む不快な臭気を減少させた食品包装用途に適したフリーラジカル硬化性液が開示されている。 Patent Document 3 discloses a) a polymerizable compound A having an acrylate group and a second ethylenically unsaturated polymerizable functional group selected from the group consisting of a vinyl ether group, an allyl ether group and an allyl ester group, and b) For reduced unpleasant odor food packaging applications comprising a polymerizable compound B consisting of a difunctional acrylate and c) a polymerizable compound C selected from the group consisting of triacrylates, tetraacrylates, pentaacrylates and hexaacrylates. Suitable free radical curable liquids are disclosed.

特許文献4には、多官能の重合性化合物及び分子量が1000以上の増感剤を含む活性光線硬化性インク組成物を、インクジェットヘッドから非吸収性又は低吸収性の繊維材料の集合体である記録基材の上に、一定のインク滴量と、記録基材とインクジェットヘッドとの間の距離を一定に保って、画像を形成し、形成された画像に酸素分圧1.5×10-2MPa以下の条件下で活性光線を照射し、画像を硬化する工程を有する、膜強度が良好で耐擦過性に優れると共に、残存モノマー量を少なく、安全性が高く低臭気の画像が形成されるインクジェット記録方法が開示されている。 In Patent Document 4, an actinic radiation-curable ink composition containing a polyfunctional polymerizable compound and a sensitizer having a molecular weight of 1000 or more is applied from an inkjet head to an assembly of non-absorbent or low-absorbent fiber materials. An image is formed on the recording substrate by keeping a constant amount of ink droplets and a constant distance between the recording substrate and the inkjet head . It has a step of irradiating an actinic ray under conditions of 2 MPa or less to cure the image, and has good film strength and excellent abrasion resistance, and the amount of residual monomer is small, and an image with high safety and low odor is formed. An ink jet recording method is disclosed.

特許文献5には、インクなどに配合される紫外線吸収剤であって、2-(2’,4’-ジヒドロキシフェニル)-2H-ベンゾトリアゾール類に、一個以上のエポキシ基を含有する化合物又はアルコール性水酸基を持つハロゲン化アルキルを反応させて得られる、アルコール性水酸基、又はアルコール性水酸基及びエポキシ基の反応性基を含有するノンブリード性の反応性紫外線吸収剤が開示されている。 Patent Document 5 discloses a compound or alcohol containing one or more epoxy groups in 2-(2′,4′-dihydroxyphenyl)-2H-benzotriazoles, which is an ultraviolet absorber to be blended in ink or the like. A non-bleeding reactive ultraviolet absorber containing a reactive group of an alcoholic hydroxyl group or an alcoholic hydroxyl group and an epoxy group obtained by reacting an alkyl halide having a reactive hydroxyl group is disclosed.

活性エネルギー線硬化型組成物は、活性エネルギー線の照射により硬化するため、溶剤系インク組成物と比べて乾燥性に優れ、基材密着性も優れるものである。近年、組成物の安全性への要求の高まりがあり、特に、食品包装や硬質容器への印刷においては硬化物からの成分の溶出(マイグレーション)が問題になることがあった。
本発明は、硬化物からのマイグレーションを抑え、硬度も上げられる活性エネルギー線硬化型組成物を提供することを目的とする。
Since the active energy ray-curable composition is cured by irradiation with an active energy ray, it is superior in drying property and adhesion to a substrate as compared with a solvent-based ink composition. In recent years, there has been an increasing demand for the safety of compositions, and in particular, elution (migration) of components from cured products has sometimes become a problem in food packaging and printing on hard containers.
An object of the present invention is to provide an active energy ray-curable composition that suppresses migration from a cured product and increases hardness.

前記課題を解決するための手段としての本発明の活性エネルギー線硬化型組成物は、下記一般式(I)で表される化合物を含むことを特徴とする活性エネルギー線硬化型組成物である。

Figure 0007336098000001
(式中Rは水素もしくはメチル基、Aは下記構造式(II)~(VII)のいずれかで表される構造であり、それぞれアルキル基、アルコキシ等の置換基を有していても良く、j及びkは0以上の整数である。Xはヘテロ原子を含む置換基を示す。nは0以上の整数、mは1以上の整数、n+mは3以上、またはn=0、m=2の整数を表す。なお、構造式(II)~(VII)中の波線はそれぞれ独立にXまたは(メタ)アクリロイル基(HC=CR-C(=O)-)との結合手を示す。)
Figure 0007336098000002
Figure 0007336098000003
Figure 0007336098000004
Figure 0007336098000005
Figure 0007336098000006
Figure 0007336098000007
The active energy ray-curable composition of the present invention as a means for solving the above problems is an active energy ray-curable composition characterized by containing a compound represented by the following general formula (I).
Figure 0007336098000001
(In the formula, R is hydrogen or a methyl group, A is a structure represented by any of the following structural formulas (II) to (VII), each of which may have a substituent such as an alkyl group or an alkoxy group, j and k are integers of 0 or more, X represents a substituent containing a hetero atom, n is an integer of 0 or more, m is an integer of 1 or more, n+m is 3 or more, or n=0, m=2 Each wavy line in structural formulas (II) to (VII) independently indicates a bond with X or a (meth)acryloyl group (H 2 C═CR—C(═O)—). )
Figure 0007336098000002
Figure 0007336098000003
Figure 0007336098000004
Figure 0007336098000005
Figure 0007336098000006
Figure 0007336098000007

本発明によると、従来における前記諸問題を解決することができ、マイグレーションを抑えた活性エネルギー線硬化型組成物を提供できる。 ADVANTAGE OF THE INVENTION According to this invention, the above-mentioned conventional problems can be solved and the active-energy-ray-curable composition which suppressed migration can be provided.

図1は、別の像形成装置(3次元立体像の形成装置)の一例を示す概略図である。FIG. 1 is a schematic diagram showing an example of another image forming apparatus (three-dimensional stereoscopic image forming apparatus). 図2は、組成物を用いて立体造形を行う方法の一例について説明する概略説明図である。FIG. 2 is a schematic explanatory diagram illustrating an example of a method for three-dimensional modeling using a composition.

下記一般式(I)で表される化合物を含むことを特徴とする活性エネルギー線硬化型組成物。

Figure 0007336098000008
(式中Rは水素もしくはメチル基、Aは下記構造式(II)~(VII)のいずれかで表される構造であり、それぞれアルキル基、アルコキシ等の置換基を有していても良く、j及びkは0以上の整数である。Xはヘテロ原子を含む置換基を示す。nは0以上の整数、mは1以上の整数、n+mは3以上、またはn=0、m=2の整数を表す。なお、構造式(II)~(VII)中の波線はそれぞれ独立にXまたは(メタ)アクリロイル基(HC=CR-C(=O)-)との結合手を示す。)
なお、上記「(メタ)アクリロイル基」という用語は、「HC=CR-C(=O)-」で表されるアクリロイル基において、Rがメチル基である場合と、Rが水素である場合との両方を示す用語である。
Figure 0007336098000009
Figure 0007336098000010
Figure 0007336098000011
Figure 0007336098000012
Figure 0007336098000013
Figure 0007336098000014
An active energy ray-curable composition comprising a compound represented by the following general formula (I).
Figure 0007336098000008
(In the formula, R is hydrogen or a methyl group, A is a structure represented by any of the following structural formulas (II) to (VII), each of which may have a substituent such as an alkyl group or an alkoxy group, j and k are integers of 0 or more, X represents a substituent containing a hetero atom, n is an integer of 0 or more, m is an integer of 1 or more, n+m is 3 or more, or n=0, m=2 Each wavy line in structural formulas (II) to (VII) independently indicates a bond with X or a (meth)acryloyl group (H 2 C═CR—C(═O)—). )
The term "(meth)acryloyl group" refers to an acryloyl group represented by "H 2 C=CR-C(=O)-" when R is a methyl group and when R is hydrogen. It is a term that indicates both when and when.
Figure 0007336098000009
Figure 0007336098000010
Figure 0007336098000011
Figure 0007336098000012
Figure 0007336098000013
Figure 0007336098000014

反応性や硬度を向上させるためには、n、mは1以上の整数、n+mは3以上の整数であることが好ましい。
上記Xはヘテロ原子を含む環状の置換基であることが好ましい。
また、前記一般式(I)の化合物の含有量は、後述するラジカル重合性化合物100質量部に対し、5質量部~20質量部であることが好ましい。
一般式(I)で表される化合物は、1種単独で使用してもよいし、2種以上を併用してもよい。具体例は、以下の構造式(A-1)~(A-20)で表される化合物などが挙げられる。
In order to improve reactivity and hardness, n and m are preferably integers of 1 or more, and n+m is preferably an integer of 3 or more.
X above is preferably a cyclic substituent containing a heteroatom.
The content of the compound of formula (I) is preferably 5 parts by mass to 20 parts by mass with respect to 100 parts by mass of the radically polymerizable compound described later.
The compounds represented by formula (I) may be used singly or in combination of two or more. Specific examples include compounds represented by the following structural formulas (A-1) to (A-20).

Figure 0007336098000015
Figure 0007336098000015
Figure 0007336098000016
Figure 0007336098000016
Figure 0007336098000017
Figure 0007336098000017

<ラジカル重合性化合物>
本発明の活性エネルギー線硬化型組成物は、上記一般式(I)で表される化合物の他にラジカル重合性化合物を含有する。前記ラジカル重合性化合物は特に制限はなく、目的に応じて適宜選択することができ、例えば、以下に示す構造式(B-1)~(B-24)で表される化合物などが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。
<Radical polymerizable compound>
The active energy ray-curable composition of the present invention contains a radically polymerizable compound in addition to the compound represented by the general formula (I). The radically polymerizable compound is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include compounds represented by the following structural formulas (B-1) to (B-24). These may be used individually by 1 type, and may use 2 or more types together.

Figure 0007336098000018
Figure 0007336098000018
Figure 0007336098000019
Figure 0007336098000019
Figure 0007336098000020
Figure 0007336098000020

<重合開始剤>
重合開始剤としては、活性エネルギー線のエネルギーによって、ラジカルやカチオンなどの活性種を生成し、重合性化合物(モノマーやオリゴマー)の重合を開始させることが可能なものであればよい。このような重合開始剤としては、公知のラジカル重合開始剤やカチオン重合開始剤、塩基発生剤等を、1種単独もしくは2種以上を組み合わせて用いることができ、中でもラジカル重合開始剤を使用することが好ましい。また、重合開始剤は、十分な硬化速度を得るために、反応性化合物(100質量部)に対し、0.2~20質量部含まれることが好ましい。
ラジカル重合開始剤としては、例えば、芳香族ケトン類、アシルフォスフィンオキサイド化合物、芳香族オニウム塩化合物、有機過酸化物、チオ化合物(チオキサントン化合物、チオフェニル基含有化合物など)、ヘキサアリールビイミダゾール化合物、ケトオキシムエステル化合物、ボレート化合物、アジニウム化合物、メタロセン化合物、活性エステル化合物、炭素ハロゲン結合を有する化合物、及びアルキルアミン化合物など公知のもの、以下の具体例(C-1)~(C-6)のものを挙げることができる。
<Polymerization initiator>
Any polymerization initiator may be used as long as it can generate active species such as radicals and cations by the energy of active energy rays to initiate polymerization of polymerizable compounds (monomers and oligomers). As such polymerization initiators, known radical polymerization initiators, cationic polymerization initiators, base generators and the like can be used singly or in combination of two or more. Among them, radical polymerization initiators are used. is preferred. Further, the polymerization initiator is preferably contained in an amount of 0.2 to 20 parts by mass with respect to the reactive compound (100 parts by mass) in order to obtain a sufficient curing speed.
Examples of radical polymerization initiators include aromatic ketones, acylphosphine oxide compounds, aromatic onium salt compounds, organic peroxides, thio compounds (thioxanthone compounds, thiophenyl group-containing compounds, etc.), hexaarylbiimidazole compounds, Known compounds such as ketoxime ester compounds, borate compounds, azinium compounds, metallocene compounds, active ester compounds, compounds having a carbon-halogen bond, and alkylamine compounds, specific examples (C-1) to (C-6) below. things can be mentioned.

Figure 0007336098000021
Figure 0007336098000021

また、上記重合開始剤に加え、重合促進剤(増感剤)を併用することもできる。重合促進剤としては、特に限定されないが、例えば、トリメチルアミン、メチルジメタノールアミン、トリエタノールアミン、p-ジエチルアミノアセトフェノン、p-ジメチルアミノ安息香酸エチル、p-ジメチルアミノ安息香酸-2-エチルヘキシル、N,N-ジメチルベンジルアミンおよび4,4’-ビス(ジエチルアミノ)ベンゾフェノンなどのアミン化合物が好ましく、その含有量は、使用する重合開始剤やその量に応じて適宜設定すればよい。 Moreover, in addition to the polymerization initiator, a polymerization accelerator (sensitizer) can be used in combination. Examples of the polymerization accelerator include, but are not limited to, trimethylamine, methyldimethanolamine, triethanolamine, p-diethylaminoacetophenone, ethyl p-dimethylaminobenzoate, 2-ethylhexyl p-dimethylaminobenzoate, N, Amine compounds such as N-dimethylbenzylamine and 4,4'-bis(diethylamino)benzophenone are preferred, and the content thereof may be appropriately set according to the polymerization initiator to be used and its amount.

<硬化手段>
本発明の硬化型組成物を硬化させる手段としては、加熱硬化または活性エネルギー線による硬化が挙げられ、これらの中でも活性エネルギー線による硬化が好ましい。
本発明の活性エネルギー線硬化型組成物を硬化させるために用いる活性エネルギー線としては、紫外線の他、電子線、α線、β線、γ線、X線等の、組成物中の重合性成分の重合反応を進める上で必要なエネルギーを付与できるものであればよく、特に限定されない。特に高エネルギーな光源を使用する場合には、重合開始剤を使用しなくても重合反応を進めることができる。また、紫外線照射の場合、環境保護の観点から水銀フリー化が強く望まれており、GaN系半導体紫外発光デバイスへの置き換えは産業的、環境的にも非常に有用である。さらに、紫外線発光ダイオード(UV-LED)及び紫外線レーザダイオード(UV-LD)は小型、高寿命、高効率、低コストであり、紫外線光源として好ましい。
<Curing means>
Examples of means for curing the curable composition of the present invention include heat curing and curing with active energy rays, and among these, curing with active energy rays is preferred.
Examples of the active energy ray used for curing the active energy ray-curable composition of the present invention include ultraviolet rays, electron beams, α rays, β rays, γ rays, X rays, and other polymerizable components in the composition. It is not particularly limited as long as it can impart the energy necessary for proceeding with the polymerization reaction. Especially when using a high-energy light source, the polymerization reaction can proceed without using a polymerization initiator. Further, in the case of ultraviolet irradiation, there is a strong desire to eliminate mercury from the viewpoint of environmental protection, and replacement with GaN-based semiconductor ultraviolet light emitting devices is very useful both industrially and environmentally. Furthermore, ultraviolet light emitting diodes (UV-LEDs) and ultraviolet laser diodes (UV-LDs) are compact, have a long life, are highly efficient, and are low in cost, and are preferred as ultraviolet light sources.

本発明の活性エネルギー線硬化型組成物は、活性エネルギー線硬化型組成物中に重合開始剤を含まなくても良い。重合開始剤を含まない場合は、重合開始剤を含まない活性エネルギー線硬化型組成物と重合開始剤とからなる組成物セットとして、用いることができる。 The active energy ray-curable composition of the present invention may not contain a polymerization initiator in the active energy ray-curable composition. When it does not contain a polymerization initiator, it can be used as a composition set consisting of an active energy ray-curable composition containing no polymerization initiator and a polymerization initiator.

<色材>
本発明の活性エネルギー線硬化型組成物は、色材を含有していてもよい。色材としては、本発明における組成物の目的や要求特性に応じて、ブラック、ホワイト、マゼンタ、シアン、イエロー、グリーン、オレンジ、金や銀等の光沢色、などを付与する種々の顔料や染料を用いることができる。色材の含有量は、所望の色濃度や組成物中における分散性等を考慮して適宜決定すればよく、特に限定されないが、組成物の総質量(100質量%)に対して、0.1~20質量%であることが好ましい。なお、本発明の活性エネルギー線硬化型組成物は、色材を含まず無色透明であってもよく、その場合には、例えば、画像を保護するためのオーバーコート層として好適である。
顔料としては、無機顔料又は有機顔料を使用することができ、1種単独で用いてもよく、2種以上を併用してもよい。
無機顔料としては、例えば、ファーネスブラック、ランプブラック、アセチレンブラック、チャネルブラック等のカーボンブラック(C.I.ピグメントブラック7)類、酸化鉄、酸化チタンを使用することができる。
有機顔料としては、例えば、不溶性アゾ顔料、縮合アゾ顔料、アゾレーキ、キレートアゾ顔料等のアゾ顔料、フタロシアニン顔料、ペリレン及びペリノン顔料、アントラキノン顔料、キナクリドン顔料、ジオキサン顔料、チオインジゴ顔料、イソインドリノン顔料、キノフタロン顔料等の多環式顔料、染料キレート(例えば、塩基性染料型キレート、酸性染料型キレート等)、染色レーキ(塩基性染料型レーキ、酸性染料型レーキ)、ニトロ顔料、ニトロソ顔料、アニリンブラック、昼光蛍光顔料が挙げられる。
また、顔料の分散性をより良好なものとするため、分散剤をさらに含んでもよい。分散剤としては、特に限定されないが、例えば、高分子分散剤などの顔料分散物を調製するのに慣用されている分散剤が挙げられる。
染料としては、例えば、酸性染料、直接染料、反応性染料、及び塩基性染料が使用可能であり、1種単独で用いてもよく、2種以上を併用してもよい。
<Color material>
The active energy ray-curable composition of the present invention may contain a coloring material. As the coloring material, various pigments and dyes that impart black, white, magenta, cyan, yellow, green, orange, lustrous colors such as gold and silver, etc., depending on the purpose and required properties of the composition in the present invention. can be used. The content of the coloring material may be appropriately determined in consideration of the desired color density, dispersibility in the composition, etc., and is not particularly limited. It is preferably 1 to 20% by mass. In addition, the active energy ray-curable composition of the present invention may be colorless and transparent without containing a coloring material, and in that case, it is suitable as an overcoat layer for protecting images, for example.
As the pigment, an inorganic pigment or an organic pigment can be used, and one kind may be used alone, or two or more kinds may be used in combination.
Examples of inorganic pigments that can be used include carbon black (CI Pigment Black 7) such as furnace black, lamp black, acetylene black, and channel black, iron oxide, and titanium oxide.
Examples of organic pigments include azo pigments such as insoluble azo pigments, condensed azo pigments, azo lakes, and chelate azo pigments, phthalocyanine pigments, perylene and perinone pigments, anthraquinone pigments, quinacridone pigments, dioxane pigments, thioindigo pigments, isoindolinone pigments, and quinophthalone. Polycyclic pigments such as pigments, dye chelates (for example, basic dye chelates, acid dye chelates, etc.), dyeing lakes (basic dye lakes, acid dye lakes), nitro pigments, nitroso pigments, aniline black, Daylight fluorescent pigments may be mentioned.
In addition, a dispersant may be further included in order to improve the dispersibility of the pigment. The dispersant is not particularly limited, but includes, for example, dispersants commonly used for preparing pigment dispersions such as polymeric dispersants.
As dyes, for example, acid dyes, direct dyes, reactive dyes, and basic dyes can be used, and they may be used singly or in combination of two or more.

<有機溶媒>
本発明の活性エネルギー線硬化型組成物は、有機溶媒を含んでもよいが、可能であれば含まない方が好ましい。有機溶媒、特に揮発性の有機溶媒を含まない(VOC(Volatile Organic Compounds)フリー)組成物であれば、当該組成物を扱う場所の安全性がより高まり、環境汚染防止を図ることも可能となる。なお、「有機溶媒」とは、例えば、エーテル、ケトン、キシレン、酢酸エチル、シクロヘキサノン、トルエンなどの一般的な非反応性の有機溶媒を意味するものであり、反応性モノマーとは区別すべきものである。また、有機溶媒を「含まない」とは、実質的に含まないことを意味し、0.1質量%未満であることが好ましい。
<Organic solvent>
Although the active energy ray-curable composition of the present invention may contain an organic solvent, it is preferable not to contain it if possible. If the composition does not contain organic solvents, especially volatile organic solvents (VOC (Volatile Organic Compounds) free), the safety of the place where the composition is handled is further increased, and it is possible to prevent environmental pollution. . The term "organic solvent" means general non-reactive organic solvents such as ether, ketone, xylene, ethyl acetate, cyclohexanone, and toluene, and should be distinguished from reactive monomers. be. In addition, "not including" an organic solvent means not including substantially an organic solvent, and it is preferably less than 0.1% by mass.

<その他の成分>
本発明の活性エネルギー線硬化型組成物は、必要に応じてその他の公知の成分を含んでもよい。その他成分としては、特に制限されないが、例えば、従来公知の、界面活性剤、重合禁止剤、レべリング剤、消泡剤、蛍光増白剤、浸透促進剤、湿潤剤(保湿剤)、定着剤、粘度安定化剤、防黴剤、防腐剤、酸化防止剤、紫外線吸収剤、キレート剤、pH調整剤、及び増粘剤などが挙げられる。
<Other ingredients>
The active energy ray-curable composition of the present invention may optionally contain other known components. Other components are not particularly limited, but include, for example, conventionally known surfactants, polymerization inhibitors, leveling agents, antifoaming agents, fluorescent whitening agents, penetration accelerators, humectants (moisturizing agents), and fixing agents. agents, viscosity stabilizers, antifungal agents, preservatives, antioxidants, ultraviolet absorbers, chelating agents, pH adjusters, and thickeners.

<活性エネルギー線硬化型組成物の調製>
本発明の活性エネルギー線硬化型組成物は、上述した各種成分を用いて作製することができ、その調製手段や条件は特に限定されないが、例えば、重合性モノマー、顔料、分散剤等をボールミル、キティーミル、ディスクミル、ピンミル、ダイノーミルなどの分散機に投入し、分散させて顔料分散液を調製し、当該顔料分散液にさらに重合性モノマー、開始剤、重合禁止剤、界面活性剤などを混合させることにより調製することができる。
<Preparation of active energy ray-curable composition>
The active energy ray-curable composition of the present invention can be produced using the various components described above, and the preparation means and conditions are not particularly limited. Put into a dispersing machine such as kitty mill, disc mill, pin mill, dyno mill, etc., disperse to prepare pigment dispersion liquid, and further mix polymerizable monomer, initiator, polymerization inhibitor, surfactant, etc. into the pigment dispersion liquid. It can be prepared by

<粘度>
本発明の活性エネルギー線硬化型組成物の粘度は、用途や適用手段に応じて適宜調整すればよく、特に限定されないが、例えば、当該組成物をノズルから吐出させるような吐出手段を適用する場合には、20℃から65℃の範囲における粘度、望ましくは25℃における粘度が3~40mPa・sが好ましく、5~15mPa・sがより好ましく、6~12mPa・sが特に好ましい。また当該粘度範囲を、上記有機溶媒を含まずに満たしていることが特に好ましい。なお、上記粘度は、東機産業株式会社製コーンプレート型回転粘度計VISCOMETER TVE-22Lにより、コーンロータ(1°34'×R24)を使用し、回転数50rpm、恒温循環水の温度を20℃~65℃の範囲で適宜設定して測定することができる。循環水の温度調整にはVISCOMATE VM-150IIIを用いることができる。
<Viscosity>
The viscosity of the active energy ray-curable composition of the present invention may be appropriately adjusted according to the application and application means, and is not particularly limited. For example, when applying a discharge means for discharging the composition from a nozzle. is preferably 3 to 40 mPa·s, more preferably 5 to 15 mPa·s, particularly preferably 6 to 12 mPa·s, in the range of 20°C to 65°C, preferably 25°C. Moreover, it is particularly preferable that the viscosity range is satisfied without including the organic solvent. The above viscosity was measured using a cone-plate rotary viscometer VISCOMETER TVE-22L manufactured by Toki Sangyo Co., Ltd., using a cone rotor (1°34′×R24), rotating at 50 rpm, and constant temperature circulating water at 20°C. Measurement can be performed by appropriately setting the temperature in the range of ~65°C. VISCOMATE VM-150III can be used to adjust the temperature of the circulating water.

<用途>
本発明の活性エネルギー線硬化型組成物の用途は、一般に活性エネルギー線硬化型材料が用いられている分野であれば特に制限はなく、目的に応じて適宜選択することができ、例えば、成形用樹脂、塗料、接着剤、絶縁材、離型剤、コーティング材、シーリング材、各種レジスト、各種光学材料などが挙げられる。
さらに、本発明の活性エネルギー線硬化型組成物は、2次元の文字や画像、各種基材への意匠塗膜を形成するだけでなく、3次元の立体像(立体造形物)を形成するための立体造形用材料としても用いることができる。また、図1や図2に示すような積層造形法(光造形法)において用いる立体構成材料(モデル材)や支持部材(サポート材)として用いてもよい。なお、図1は、本発明の活性エネルギー線硬化型組成物を所定領域に吐出し、活性エネルギー線を照射して硬化させたものを順次積層して立体造形を行う方法である。
<Application>
The application of the active energy ray-curable composition of the present invention is not particularly limited as long as it is a field where active energy ray-curable materials are generally used, and can be appropriately selected according to the purpose. Examples include resins, paints, adhesives, insulating materials, release agents, coating materials, sealing materials, various resists, and various optical materials.
Furthermore, the active energy ray-curable composition of the present invention not only forms two-dimensional characters, images, and design coatings on various substrates, but also forms a three-dimensional three-dimensional image (three-dimensional object). It can also be used as a material for three-dimensional modeling. Moreover, it may be used as a three-dimensional structural material (model material) or a supporting member (supporting material) used in a layered manufacturing method (stereolithography method) as shown in FIGS. 1 and 2 . In addition, FIG. 1 shows a method of discharging the active energy ray-curable composition of the present invention to a predetermined region, irradiating the active energy ray to harden the composition, and stacking them one after another to form a three-dimensional model.

図1の像形成装置39は、インクジェットヘッドを配列したヘッドユニット(AB方向に可動)を用いて、造形物用吐出ヘッドユニット30から第一の活性エネルギー線硬化型組成物を、支持体用吐出ヘッドユニット31、32から第一の活性エネルギー線硬化型組成物とは組成が異なる第二の活性エネルギー線硬化型組成物を吐出し、隣接した紫外線照射手段33、34でこれら各組成物を硬化しながら積層するものである。より具体的には、例えば、造形物支持基板37上に、第二の活性エネルギー線硬化型組成物を支持体用吐出ヘッドユニット31、32から吐出し、活性エネルギー線を照射して固化させて溜部を有する第一の支持体層を形成した後、当該溜部に第一の活性エネルギー線硬化型組成物を造形物用吐出ヘッドユニット30から吐出し、活性エネルギー線を照射して固化させて第一の造形物層を形成する工程を、積層回数に合わせて、上下方向に可動なステージ38を下げながら複数回繰り返すことで、支持体層と造形物層を積層して立体造形物35を製作する。その後、必要に応じて支持体積層部36は除去される。なお、図1では、造形物用吐出ヘッドユニット30は1つしか設けていないが、2つ以上設けることもできる。 The image forming apparatus 39 in FIG. 1 uses a head unit (movable in the AB direction) in which inkjet heads are arranged to eject the first active energy ray-curable composition from the ejection head unit 30 for a modeled object. A second active energy ray-curable composition having a composition different from that of the first active energy ray-curable composition is ejected from the head units 31 and 32, and these compositions are cured by adjacent ultraviolet irradiation means 33 and 34. It is laminated while doing so. More specifically, for example, the second active energy ray-curable composition is ejected from the support ejection head units 31 and 32 onto the shaped object support substrate 37, and is irradiated with an active energy ray to be solidified. After forming the first support layer having a reservoir, the first active energy ray-curable composition is discharged from the discharge head unit 30 for a modeled object into the reservoir, and is irradiated with an active energy ray to be solidified. By repeating the step of forming the first model layer by pressing the support layer and the model layer a plurality of times while lowering the vertically movable stage 38 according to the number of layers, the support layer and the model layer are laminated to form the three-dimensional model 35 . to manufacture. Thereafter, the support laminate 36 is removed as required. Although only one ejection head unit 30 is provided in FIG. 1, two or more may be provided.

図2は、本発明の活性エネルギー線硬化型組成物5の貯留プール(収容部)1に活性エネルギー線4を照射して所定形状の硬化層6を可動ステージ3上に形成し、これを順次積層して立体造形を行う方法である。 FIG. 2 shows that a storage pool (receiving portion) 1 for an active energy ray-curable composition 5 of the present invention is irradiated with an active energy ray 4 to form a cured layer 6 having a predetermined shape on a movable stage 3, which is sequentially formed. This is a method of layering and three-dimensional modeling.

本発明の活性エネルギー線硬化型組成物を用いて立体造形物を造形するための立体造形装置としては、公知のものを使用することができ、特に限定されないが、例えば、該組成物の収容手段、供給手段、吐出手段や活性エネルギー線照射手段等を備えるものが挙げられる。 As a stereolithography apparatus for molding a three-dimensional object using the active energy ray-curable composition of the present invention, a known apparatus can be used, and is not particularly limited. For example, means for containing the composition , supply means, discharge means, active energy ray irradiation means, and the like.

また、本発明は、活性エネルギー線硬化型組成物を硬化させて得られた硬化物や当該硬化物が基材上に形成された構造体を加工してなる成形加工品も含むが、特に重合性歯科材料として用いることが好ましい。前記成形加工品は、例えば、シート状、フィルム状に形成された硬化物や構造体に対して、加熱延伸や打ち抜き加工等の成形加工を施したものであり、例えば、自動車、OA機器、電気・電子機器、カメラ等のメーターや操作部のパネルなど、表面を加飾後に成形することが必要な用途に好適に使用される。
上記基材としては、特に限定されず、目的に応じて適宜選択することができ、例えば、紙、糸、繊維、布帛、皮革、金属、プラスチック、ガラス、木材、セラミックス、又はこれらの複合材料などが挙げられ、加工性の観点からはプラスチック基材が好ましい。
In addition, the present invention includes a molded product obtained by processing a cured product obtained by curing an active energy ray-curable composition or a structure in which the cured product is formed on a substrate, but particularly polymerized It is preferably used as a sexual dental material. The molded article is, for example, a sheet-shaped or film-shaped cured product or structure subjected to molding such as heat stretching or punching.・It is suitable for applications that require molding after surface decoration, such as electronic equipment, meters for cameras, and operation panels.
The base material is not particularly limited and can be appropriately selected depending on the purpose. Examples include paper, thread, fiber, fabric, leather, metal, plastic, glass, wood, ceramics, composite materials thereof, and the like. and a plastic substrate is preferable from the viewpoint of workability.

<組成物収容容器>
本発明の組成物収容容器は、活性エネルギー線硬化型組成物、または重合性歯科材料組成物が収容された状態の容器を意味し、上記のような用途に供する際に好適である。また、容器それ自体の形状や大きさ、材質等は、用途や使い方に適したものとすればよく、特に限定されないが、その材質は光を透過しない遮光性材料であるか、または容器が遮光性シート等で覆われていることが望ましい。
<Composition storage container>
The composition container of the present invention means a container containing an active energy ray-curable composition or a polymerizable dental material composition, and is suitable for the above uses. The shape, size, material, etc. of the container itself are not particularly limited as long as they are suitable for the application and usage. should be covered with a protective sheet or the like.

以下に本発明の実施例を示すが、本発明の範囲はこれらの合成例、実施例によって限定されるものではない。 Examples of the present invention are shown below, but the scope of the present invention is not limited by these Synthesis Examples and Examples.

一般式(I)で表される化合物の例として示した前記(A-1)~(A-20)の化合物の内、A-1、A-2、A-3、A-6、A-7、A-8、A-12の合成例及び各化合物のNMRスペクトル値を以下に示す。 Among the compounds (A-1) to (A-20) shown as examples of the compound represented by the general formula (I), A-1, A-2, A-3, A-6, A- Synthesis examples of 7, A-8 and A-12 and NMR spectrum values of each compound are shown below.

(合成例1)
(A-1)の合成例
100mL三つ口フラスコに、トリメチロールプロパン トリアクリレート(ARONIX M-309、東亞合成製)5.93g(20mmol)を仕込み、氷冷しながらモルホリン 5.40g(62mmol)を滴下した。滴下終了後、室温に戻して1時間撹拌した。この粗生成物をシリカゲルカラムクロマトグラフィー(充填材:ワコーゲル C-300、展開溶媒:酢酸エチル)で精製し、無色の液体である目的物7.0g(収率63%)を得た。
(NMRスペクトル値)
1H-NMR (500MHz, CDCl3): δ0.90(t, 3H), 1.49(q, 2H), 2.45(br, 12H), 2.51(t, 6H), 2.66(t, 6H), 3.68(t, 12H), 4.06(s, 6H)
(Synthesis example 1)
Synthesis example of (A-1) A 100 mL three-necked flask was charged with 5.93 g (20 mmol) of trimethylolpropane triacrylate (ARONIX M-309, manufactured by Toagosei), and 5.40 g (62 mmol) of morpholine was cooled with ice. was dripped. After completion of the dropwise addition, the mixture was returned to room temperature and stirred for 1 hour. This crude product was purified by silica gel column chromatography (filler: Wakogel C-300, developing solvent: ethyl acetate) to obtain 7.0 g of the desired product as a colorless liquid (yield 63%).
(NMR spectrum value)
1 H-NMR (500 MHz, CDCl 3 ): δ0.90(t, 3H), 1.49(q, 2H), 2.45(br, 12H), 2.51(t, 6H), 2.66(t, 6H), 3.68( t, 12H), 4.06(s, 6H)

(合成例2)
(A-2)の合成例
100mL三つ口フラスコに、トリメチロールプロパン トリアクリレート(ARONIX M-309、東亞合成製)8.89g(30mmol)を仕込み、氷冷しながらモルホリン 5.23g(60mmol)を滴下した。滴下終了後、室温に戻して2時間撹拌した。この粗生成物をシリカゲルカラムクロマトグラフィー(充填材:ワコーゲル C-300、展開溶媒:酢酸エチル)で精製し、無色の液体である目的物1.8g(収率12%)を得た。
(NMRスペクトル値)
1H-NMR (500MHz, CDCl3): δ0.91(t, 3H), 1.51(q, 2H), 2.45(br, 8H), 2.51(t, 4H), 2.66(t, 4H), 3.68(t, 8H), 4.08(s, 4H), 4.12(s, 2H)、5.86-5.88(dd, 1H), 6.09-6.15(q, 1H), 6.39-6.43(dd, 1H)
(Synthesis example 2)
Synthesis example of (A-2) In a 100 mL three-necked flask, 8.89 g (30 mmol) of trimethylolpropane triacrylate (ARONIX M-309, manufactured by Toagosei Co., Ltd.) was charged, and 5.23 g (60 mmol) of morpholine was added while cooling with ice. was dripped. After completion of the dropwise addition, the mixture was returned to room temperature and stirred for 2 hours. This crude product was purified by silica gel column chromatography (filler: Wakogel C-300, developing solvent: ethyl acetate) to obtain 1.8 g of the desired product as a colorless liquid (yield 12%).
(NMR spectrum value)
1 H-NMR (500 MHz, CDCl 3 ): δ0.91(t, 3H), 1.51(q, 2H), 2.45(br, 8H), 2.51(t, 4H), 2.66(t, 4H), 3.68( t, 8H), 4.08(s, 4H), 4.12(s, 2H), 5.86-5.88(dd, 1H), 6.09-6.15(q, 1H), 6.39-6.43(dd, 1H)

(合成例3)
(A-3)の合成例
100mL三つ口フラスコに、トリメチロールプロパン トリアクリレート(ARONIX M-309、東亞合成製)11.85g(40mmol)および酢酸エチル20mlを仕込み、氷冷しながらモルホリン 3.48g(40mmol)を滴下した。滴下終了後、室温に戻して1時間撹拌した後、重合禁止剤(MEHQ)を加えた。この粗生成物をシリカゲルカラムクロマトグラフィー(充填材:ワコーゲル C-300、展開溶媒:ヘキサン/酢酸エチル=1/1)で精製し、無色の液体である目的物4.5g(収率30%)を得た。
(NMRスペクトル値)
1H-NMR (500MHz, CDCl3): δ0.92(t, 3H), 1.53(q, 2H), 2.44(br, 4H), 2.51(t, 2H), 2.66(t, 2H), 3.67(t, 4H), 4.11(s, 2H), 4.15(s, 4H)、5.85-5.88(dd, 2H), 6.09-6.15(q, 2H), 6.39-6.43(dd, 2H)
(Synthesis Example 3)
Synthesis Example of (A-3) A 100 mL three-necked flask was charged with 11.85 g (40 mmol) of trimethylolpropane triacrylate (ARONIX M-309, manufactured by Toagosei Co., Ltd.) and 20 mL of ethyl acetate, and morpholine was added while cooling with ice. 48 g (40 mmol) was added dropwise. After dropping, the mixture was returned to room temperature and stirred for 1 hour, and then a polymerization inhibitor (MEHQ) was added. This crude product was purified by silica gel column chromatography (filler: Wakogel C-300, developing solvent: hexane/ethyl acetate = 1/1) to give 4.5 g of the desired product as a colorless liquid (yield 30%). got
(NMR spectrum value)
1 H-NMR (500 MHz, CDCl 3 ): δ0.92(t, 3H), 1.53(q, 2H), 2.44(br, 4H), 2.51(t, 2H), 2.66(t, 2H), 3.67( t, 4H), 4.11(s, 2H), 4.15(s, 4H), 5.85-5.88(dd, 2H), 6.09-6.15(q, 2H), 6.39-6.43(dd, 2H)

(合成例4)
(A-6)の合成例
100mL三つ口フラスコに、トリメチロールプロパン トリメタクリレート(SR-350、アルケマ製)10.15g(30mmol)を仕込み、モルホリン 3.13g(36mmol)を滴下した。その後、45℃で12時間加熱反応した。この粗生成物をシリカゲルカラムクロマトグラフィー(充填材:ワコーゲル C-300、展開溶媒:ヘキサン/酢酸エチル=3/1)で精製し、無色の液体である目的物4.9g(収率38%)を得た。
(NMRスペクトル値)
1H-NMR (500MHz, CDCl3): δ0.93(t, 3H), 1.13(d, 3H), 1.56(q, 2H), 1.95(t, 6H), 2.27(q, 1H), 2.36(br, 2H), ,2.47(br, 2H), 2.63(t, 1H), 2.70-2.73(m, 1H), 3.64(t, 4H), 4.11(d, 2H), 4.14(s, 4H), 5.58-5.59(m, 2H), 6.10-6.11(m, 2H)
(Synthesis Example 4)
Synthesis Example of (A-6) A 100 mL three-necked flask was charged with 10.15 g (30 mmol) of trimethylolpropane trimethacrylate (SR-350, manufactured by Arkema), and 3.13 g (36 mmol) of morpholine was added dropwise. After that, the mixture was heated and reacted at 45° C. for 12 hours. This crude product was purified by silica gel column chromatography (filler: Wakogel C-300, developing solvent: hexane/ethyl acetate = 3/1) to give 4.9 g of the desired product as a colorless liquid (yield 38%). got
(NMR spectrum value)
1 H-NMR (500 MHz, CDCl 3 ): δ0.93(t, 3H), 1.13(d, 3H), 1.56(q, 2H), 1.95(t, 6H), 2.27(q, 1H), 2.36( br, 2H), ,2.47(br, 2H), 2.63(t, 1H), 2.70-2.73(m, 1H), 3.64(t, 4H), 4.11(d, 2H), 4.14(s, 4H), 5.58-5.59(m, 2H), 6.10-6.11(m, 2H)

(合成例5)
(A-7)の合成例
100mL三つ口フラスコに、グリセリン トリアクリレート(ARONIX MT-3547、東亞合成製)3.62g(30mmol)、酢酸エチル20mlを仕込み、氷冷しながらモルホリン 8.10g(93mmol)を滴下した。滴下終了後、室温に戻して1時間撹拌した。この粗生成物をシリカゲルカラムクロマトグラフィー(充填材:ワコーゲル C-300、展開溶媒:酢酸エチル)で精製し、無色の液体である目的物9.0g(収率58%)を得た。
(NMRスペクトル値)
1H-NMR (500MHz, CDCl3): δ2.45(br, 12H), 2.52(m, 6H), 2.67(m, 6H), 3.69(t, 12H), 4.21(dd, 2H), 4.32(dd, 2H), 5.28(m, 1H)
(Synthesis Example 5)
Synthesis example of (A-7)
A 100-mL three-necked flask was charged with 3.62 g (30 mmol) of glycerin triacrylate (ARONIX MT-3547, manufactured by Toagosei) and 20 ml of ethyl acetate, and 8.10 g (93 mmol) of morpholine was added dropwise while cooling with ice. After completion of the dropwise addition, the mixture was returned to room temperature and stirred for 1 hour. This crude product was purified by silica gel column chromatography (filler: Wakogel C-300, developing solvent: ethyl acetate) to obtain 9.0 g of the desired product as a colorless liquid (yield 58%).
(NMR spectrum value)
1 H-NMR (500 MHz, CDCl 3 ): δ2.45(br, 12H), 2.52(m, 6H), 2.67(m, 6H), 3.69(t, 12H), 4.21(dd, 2H), 4.32( dd, 2H), 5.28(m, 1H)

(合成例6)
(A-8)の合成例
窒素ガス置換した300mL三つ口フラスコに、テトラヒドロフラン-2-カルボン酸(東京化成工業製)1.69g(14.5mmol)、脱水ジクロロメタン50mL、トリエチルアミン5.45mL(39.3mmol)、4-ジメチルアミノピリジン(東京化成工業製)0.177g(1.45mmol)および2-メチル-6-ニトロ安息香酸無水物(東京化成工業製)5g(14.5mmol)を仕込み室温にて10分間撹拌した。その後、この反応液にトリメチロールプロパン0.54g(4.02mmol)を少しずつ加え、室温で12時間撹拌した。
この反応液を分液漏斗に移し、飽和炭酸水素ナトリウム水溶液、次いで飽和食塩水の順で洗浄し、有機相に硫酸ナトリウムを加えて乾燥したのち溶媒を減圧留去した。この粗精製物をシリカゲルカラムクロマトグラフィー(充填材:ワコーゲル C-300、展開溶媒:ヘキサン/酢酸エチル=1/1)で精製し、無色の液体である目的物1.6g(収率94%)を得た。
(NMRスペクトル値)
1H-NMR (500MHz, CDCl3): δ0.91(t, 3H), 1.49(q, 2H), 1.93(m, 6H), 1.96(m, 3H), 2.25(m, 3H), 3.93(m, 3H), 3.99(m, 3H), 4.09(m, 6H), 4.46(q, 3H)
(Synthesis Example 6)
Synthesis example of (A-8)
A 300 mL three-necked flask purged with nitrogen gas was charged with 1.69 g (14.5 mmol) of tetrahydrofuran-2-carboxylic acid (manufactured by Tokyo Kasei Kogyo), 50 mL of dehydrated dichloromethane, 5.45 mL of triethylamine (39.3 mmol), and 4-dimethylamino. 0.177 g (1.45 mmol) of pyridine (manufactured by Tokyo Chemical Industry Co., Ltd.) and 5 g (14.5 mmol) of 2-methyl-6-nitrobenzoic anhydride (manufactured by Tokyo Chemical Industry Co., Ltd.) were charged and stirred at room temperature for 10 minutes. After that, 0.54 g (4.02 mmol) of trimethylolpropane was added little by little to this reaction solution, and the mixture was stirred at room temperature for 12 hours.
The reaction solution was transferred to a separatory funnel, washed with a saturated aqueous solution of sodium bicarbonate and then with a saturated saline solution in that order, sodium sulfate was added to the organic phase to dry it, and then the solvent was distilled off under reduced pressure. This crude product was purified by silica gel column chromatography (filler: Wakogel C-300, developing solvent: hexane/ethyl acetate = 1/1) to obtain 1.6 g of the target product as a colorless liquid (yield 94%). got
(NMR spectrum value)
1 H-NMR (500 MHz, CDCl 3 ): δ0.91(t, 3H), 1.49(q, 2H), 1.93(m, 6H), 1.96(m, 3H), 2.25(m, 3H), 3.93( m, 3H), 3.99(m, 3H), 4.09(m, 6H), 4.46(q, 3H)

(合成例7)
(A-12)の合成例
50mL三つ口フラスコに、トリプロピレングリコール ジアクリレート(ARONIX M-220、東亞合成製)3.00g(10mmol)を仕込み、氷冷しながらモルホリン 1.92g(22mmol)を滴下した。滴下終了後、室温に戻して1時間撹拌した。この粗生成物をシリカゲルカラムクロマトグラフィー(充填材:ワコーゲル C-300、展開溶媒:ヘキサン/酢酸エチル=1/2)で精製し、無色の液体である目的物4.4g(収率93%)を得た。
(NMRスペクトル値)
1H-NMR (500MHz, CDCl3): δ 1.11-1.24(m, 9H), 2.46(br, 8H), 2.49(m, 4H), 2.68(m, 4H), 3.30-3.61(m, 6H), 3.69(t, 8H), 5.01-5.11(m, 3H)
(Synthesis Example 7)
Synthesis example of (A-12) A 50 mL three-necked flask was charged with 3.00 g (10 mmol) of tripropylene glycol diacrylate (ARONIX M-220, manufactured by Toagosei), and 1.92 g (22 mmol) of morpholine was added while cooling with ice. was dripped. After completion of the dropwise addition, the mixture was returned to room temperature and stirred for 1 hour. This crude product was purified by silica gel column chromatography (filler: Wakogel C-300, developing solvent: hexane/ethyl acetate = 1/2) to obtain 4.4 g of the desired product as a colorless liquid (yield 93%). got
(NMR spectrum value)
1 H-NMR (500 MHz, CDCl 3 ): δ 1.11-1.24(m, 9H), 2.46(br, 8H), 2.49(m, 4H), 2.68(m, 4H), 3.30-3.61(m, 6H) , 3.69(t, 8H), 5.01-5.11(m, 3H)

<活性エネルギー線硬化型組成物の作製>
表1に示す材料と含有量(質量部)に基づき、常法により実施例及び比較例の活性エネルギー線硬化型組成物を調製した。なお、表1中の各化合物を表している符号は、前記において例示した化合物の符号と一致する。
各実施例及び比較例の活性エネルギー線硬化型組成物について、溶出量の評価に関してはPETフィルム(東洋紡製E5100、厚さ100μm)上に10μmの膜を作製し、また、鉛筆硬度の評価に関しては、PC(ポリカーボネート)基板(三菱瓦斯化学製NF-2000、厚さ500μm)上に10μmの膜を作製し、それぞれの膜をウシオ電機製メタルハライドランプ(1000mJ/cm)で硬化させた。
<Preparation of active energy ray-curable composition>
Based on the materials and contents (parts by mass) shown in Table 1, active energy ray-curable compositions of Examples and Comparative Examples were prepared by a conventional method. In addition, the code|symbol which represents each compound in Table 1 corresponds with the code|symbol of the compound illustrated above.
For the active energy ray-curable composition of each example and comparative example, a 10 μm film was prepared on a PET film (Toyobo E5100, thickness 100 μm) for evaluation of the amount of elution, and for evaluation of pencil hardness. , a 10 μm-thick film was formed on a PC (polycarbonate) substrate (NF-2000 manufactured by Mitsubishi Gas Chemical, thickness 500 μm), and each film was cured with a metal halide lamp (1000 mJ/cm 2 ) manufactured by Ushio Electric.

なお、表中の略号はそれぞれ以下のものを表す。
B-1 :東亞合成株式会社 M-220
B-2 :東亞合成株式会社 M-309
B-10:日本化薬株式会社 R-684
B-16:大阪有機化学工業株式会社 ビスコート#150
C-1 :BASF社 Irgcure 907
C-4 :BASF社 Lucirin TPO
CB :チバ・ジャパン株式会社製、MICROLITH Black C-K (カーボンブラック顔料)
Blue:チバ・ジャパン株式会社製、MICROLITH Blue 4G-K
The abbreviations in the table represent the following respectively.
B-1: Toagosei Co., Ltd. M-220
B-2: Toagosei Co., Ltd. M-309
B-10: Nippon Kayaku Co., Ltd. R-684
B-16: Osaka Organic Chemical Industry Co., Ltd. Viscoat #150
C-1: BASF Irgcure 907
C-4: BASF Lucirin TPO
CB: MICROLITH Black CK (carbon black pigment) manufactured by Ciba Japan Co., Ltd.
Blue: MICROLITH Blue 4G-K manufactured by Ciba Japan Co., Ltd.

<溶出量>
各実施例及び比較例の活性エネルギー線硬化型組成物について、以下のように評価を行った。
(1)PETフィルム上の硬化膜を1cm角に切り出す。
(2)(1)のフィルムを溶媒(アセトン、アセトニトリル)1.67gに浸し、24h放置する。
(3)溶媒を濾過し、GC-MS、LC-MSで分析し、溶出量を評価する。
評価基準は以下のとおりである。
◎:溶出量1ppm未満
〇:溶出量1ppm以上5ppm未満
△:溶出量5ppm以上10ppm未満
×:溶出量10ppm以上
<Elution amount>
The active energy ray-curable composition of each example and comparative example was evaluated as follows.
(1) A cured film on a PET film is cut into 1 cm squares.
(2) The film of (1) is immersed in 1.67 g of solvent (acetone, acetonitrile) and allowed to stand for 24 hours.
(3) Filter the solvent and analyze by GC-MS and LC-MS to evaluate the amount of elution.
Evaluation criteria are as follows.
◎: Elution amount less than 1 ppm ○: Elution amount 1 ppm or more and less than 5 ppm △: Elution amount 5 ppm or more and less than 10 ppm ×: Elution amount 10 ppm or more

<鉛筆硬度>
鉛筆硬度試験はJIS K5600-5-4(引っかき硬度:鉛筆法)に基づいて行った。
結果を表1に示した。
<Pencil hardness>
The pencil hardness test was conducted according to JIS K5600-5-4 (scratch hardness: pencil method).
Table 1 shows the results.

Figure 0007336098000022
Figure 0007336098000022

表1の結果より、本発明の活性エネルギー線硬化型組成物は、鉛筆硬度が上昇し、重合開始剤の溶出量も抑えられることがわかる。 From the results in Table 1, it can be seen that the active energy ray-curable composition of the present invention increases the pencil hardness and suppresses the elution amount of the polymerization initiator.

<インクジェット用インクとしての応用例>
前記実施例1~3の活性エネルギー線硬化型組成物からなる3種類のインクジェット用インクについて、以下のようにして、硬化性及びインク吐出性を評価した。
[評価方法]
表1に示す材料と含有量(質量部)に基づき作製した各インクジェット用インクを、インクジェット吐出装置(株式会社リコー製、ヘッド:リコープリンティングシステムズ社製GEN4)に装填し、市販のポリエチレンテレフタレート(PET)フィルム(東洋紡株式会社製、E5100、厚み100μm)上に、インクを吐出し、平均厚み10μmに形成したベタ塗膜に対し、UV照射機(LH6、フュージョンシステムズジャパン社製)により、0.2W/cm2の照度で硬化させた。
その結果、いずれのインクジェット用インクも低粘度(40℃で10mPa・s~15mPa・s)であり、インク吐出性は良好であった。
<Example of application as inkjet ink>
Three types of inkjet inks composed of the active energy ray-curable compositions of Examples 1 to 3 were evaluated for curability and ink jettability in the following manner.
[Evaluation method]
Each inkjet ink prepared based on the materials and contents (mass parts) shown in Table 1 was loaded into an inkjet ejection device (manufactured by Ricoh Co., Ltd., head: GEN4 manufactured by Ricoh Printing Systems), and commercially available polyethylene terephthalate (PET) ) A film (manufactured by Toyobo Co., Ltd., E5100, thickness 100 μm) is discharged with ink, and a solid coating film formed to an average thickness of 10 μm is irradiated with a UV irradiation machine (LH6, manufactured by Fusion Systems Japan) at 0.2 W. /cm2.
As a result, all of the inkjet inks had low viscosities (10 mPa·s to 15 mPa·s at 40° C.) and good ink ejection properties.

本発明は下記(1)の活性エネルギー線硬化型組成物にかかるものであるが、下記(2)~(15)を実施形態として含む。
(1)下記一般式(I)で表される化合物を含むことを特徴とする活性エネルギー線硬化型組成物。

Figure 0007336098000023
(式中Rは水素もしくはメチル基、Aは下記構造式(II)~(VII)のいずれかで表される構造であり、それぞれアルキル基、アルコキシ等の置換基を有していても良く、j及びkは0以上の整数である。Xはヘテロ原子を含む置換基を示す。nは0以上の整数、mは1以上の整数、n+mは3以上、またはn=0、m=2の整数を表す。なお、構造式(II)~(VII)中の波線はそれぞれ独立にXまたは(メタ)アクリロイル基(HC=CR-C(=O)-)との結合手を示す。)
Figure 0007336098000024
Figure 0007336098000025
Figure 0007336098000026
Figure 0007336098000027
Figure 0007336098000028
Figure 0007336098000029
(2)前記活性エネルギー線硬化型組成物が、更にラジカル重合性化合物を含み、前記ラジカル重合性化合物100質量部に対し、前記一般式(I)で表される化合物を4質量部~20質量部含むことを特徴とする上記(1)に記載の活性エネルギー線硬化型組成物。
(3)前記一般式(I)で表される化合物が、n、mは1以上の整数、n+mは3以上の整数であることを特徴とする上記(1)又は(2)に記載の活性エネルギー線硬化型組成物。
(4)前記一般式(I)中、Xがヘテロ原子を含む環状の置換基であることを特徴とする上記(1)乃至(3)のいずれか1項に記載の活性エネルギー線硬化型組成物。
(5)前記活性エネルギー線硬化型組成物が、重合開始剤を含むことを特徴とする上記(1)乃至(4)のいずれか1項に記載の活性エネルギー線硬化型組成物。
(6)前記一般式(I)で表される化合物が、下記の(A-1)~(A-20)で表される構造を有する化合物である上記(1)乃至(5)のいずれか1項に記載の活性エネルギー線硬化型組成物。
Figure 0007336098000030
Figure 0007336098000031
Figure 0007336098000032
(7)立体造形用材料であることを特徴とする上記(1)乃至(6)のいずれか1項に記載の活性エネルギー線硬化型組成物。
(8)上記(1)乃至(7)のいずれか1項に記載の活性エネルギー線硬化型組成物を用いたことを特徴とする活性エネルギー線硬化型インク組成物。
(9)上記(8)に記載の活性エネルギー線硬化型インク組成物を用いたことを特徴とする活性エネルギー線硬化型インクジェット用インク組成物。
(10)上記(1)乃至(9)のいずれか1項に記載の組成物が収容された組成物収容容器。
(11)上記(1)乃至(9)のいずれか1項に記載の組成物が収容された収容部と、活性エネルギー線を照射するための照射手段とを備えたことを特徴とする2次元または3次元の像形成装置。
(12)上記(1)乃至(9)のいずれか1項に記載の組成物に活性エネルギー線を照射する照射工程を有する、2次元または3次元の像形成方法。
(13)上記(1)乃至(9)のいずれか1項に記載の組成物の硬化物。
(14)基材上に、上記(13)に記載の硬化物からなる表面加飾を有することを特徴とする加飾体。
(15)下記一般式(I)で表される化合物を含むことを特徴とする活性エネルギー線硬化型組成物。
Figure 0007336098000033
(式中Rは水素もしくはメチル基、Aは多価アルコール残基、Xはヘテロ原子を含む置換基を示す。nは0以上の整数、mは1以上の整数、n+mは3以上、またはn=0、m=2の整数を表す。) The present invention relates to the active energy ray-curable composition of (1) below, and includes the following (2) to (15) as embodiments.
(1) An active energy ray-curable composition comprising a compound represented by the following general formula (I).
Figure 0007336098000023
(In the formula, R is hydrogen or a methyl group, A is a structure represented by any of the following structural formulas (II) to (VII), each of which may have a substituent such as an alkyl group or an alkoxy group, j and k are integers of 0 or more, X represents a substituent containing a hetero atom, n is an integer of 0 or more, m is an integer of 1 or more, n+m is 3 or more, or n=0, m=2 Each wavy line in structural formulas (II) to (VII) independently indicates a bond with X or a (meth)acryloyl group (H 2 C═CR—C(═O)—). )
Figure 0007336098000024
Figure 0007336098000025
Figure 0007336098000026
Figure 0007336098000027
Figure 0007336098000028
Figure 0007336098000029
(2) The active energy ray-curable composition further contains a radically polymerizable compound, and 4 parts by mass to 20 parts by mass of the compound represented by the general formula (I) with respect to 100 parts by mass of the radically polymerizable compound. The active energy ray-curable composition according to (1) above, characterized in that it contains
(3) The activity according to (1) or (2) above, wherein n and m are integers of 1 or more and n+m is an integer of 3 or more in the compound represented by the general formula (I). Energy ray-curable composition.
(4) The active energy ray-curable composition according to any one of (1) to (3) above, wherein X in general formula (I) is a heteroatom-containing cyclic substituent. thing.
(5) The active energy ray-curable composition according to any one of (1) to (4) above, which contains a polymerization initiator.
(6) Any one of the above (1) to (5), wherein the compound represented by the general formula (I) is a compound having a structure represented by the following (A-1) to (A-20) 1. The active energy ray-curable composition according to item 1.
Figure 0007336098000030
Figure 0007336098000031
Figure 0007336098000032
(7) The active energy ray-curable composition according to any one of (1) to (6) above, which is a material for three-dimensional modeling.
(8) An active energy ray-curable ink composition using the active energy ray-curable composition according to any one of (1) to (7) above.
(9) An active-energy-ray-curable ink composition for inkjet, characterized by using the active-energy-ray-curable ink composition described in (8) above.
(10) A composition container containing the composition according to any one of (1) to (9) above.
(11) A two-dimensional composition comprising: a container containing the composition according to any one of (1) to (9) above; and irradiation means for irradiating an active energy ray. Or a three-dimensional imager.
(12) A two-dimensional or three-dimensional image forming method, comprising an irradiation step of irradiating the composition according to any one of (1) to (9) above with an active energy ray.
(13) A cured product of the composition according to any one of (1) to (9) above.
(14) A decorated body comprising a base material and a surface decorated with the cured product according to (13) above.
(15) An active energy ray-curable composition comprising a compound represented by the following general formula (I).
Figure 0007336098000033
(In the formula, R is hydrogen or a methyl group, A is a polyhydric alcohol residue, and X is a substituent containing a heteroatom. n is an integer of 0 or more, m is an integer of 1 or more, n+m is 3 or more, or n = 0, m = represents an integer of 2.)

1 貯留プール(収容部)
3 可動ステージ
4 活性エネルギー線
5 活性エネルギー線硬化型組成物
6 硬化層
30 造形物用吐出ヘッドユニット
31、32 支持体用吐出ヘッドユニット
33、34 紫外線照射手段
35 立体造形物
36 支持体積層部
37 造形物支持基板
38 ステージ
39 像形成装置
1 storage pool (accommodation part)
3 Movable stage 4 Active energy ray 5 Active energy ray-curable composition 6 Curing layer 30 Ejection head units 31 and 32 for molded object Ejection head units 33 and 34 for support Ultraviolet irradiation means 35 Three-dimensional object 36 Support laminate 37 Modeled object support substrate 38 Stage 39 Image forming device

特表2015-531809号公報Japanese Patent Publication No. 2015-531809 特開2017-110200号公報Japanese Patent Application Laid-Open No. 2017-110200 特許第5959602号公報Japanese Patent No. 5959602 特許第5788918号公報Japanese Patent No. 5788918 特開2003-253248号公報JP 2003-253248 A

Claims (13)

下記一般式(I)で表される化合物及びラジカル重合性化合物を含むことを特徴とする活性エネルギー線硬化型組成物。
Figure 0007336098000034
(式中Rは水素もしくはメチル基、Aは下記構造式(II)~(V)のいずれかで表される構造である。Xは下記構造式(X-1)~(X-4)のいずれかで表される構造である。nは0以上の整数、mは1以上の整数、n+mは3以上の整数を表す。なお、構造式(II)~(V)中の波線はそれぞれ独立にXまたは(メタ)アクリロイル基(HC=CR-C(=O)-)との結合手を示し、構造式(X-1)~(X-4)中の*印は結合部位を示す。)
Figure 0007336098000035
Figure 0007336098000036
Figure 0007336098000037
Figure 0007336098000038
Figure 0007336098000039
An active energy ray-curable composition comprising a compound represented by the following general formula (I) and a radically polymerizable compound.
Figure 0007336098000034
(In the formula, R is hydrogen or a methyl group, A is a structure represented by any of the following structural formulas (II) to (V). X is the following structural formulas (X-1) to (X-4). n is an integer of 0 or more, m is an integer of 1 or more, and n+m is an integer of 3 or more, and each wavy line in structural formulas (II) to (V) is independent. indicates a bond with X or a (meth)acryloyl group (H 2 C=CR-C(=O)-), and the * marks in structural formulas (X-1) to (X-4) indicate the binding sites. show.)
Figure 0007336098000035
Figure 0007336098000036
Figure 0007336098000037
Figure 0007336098000038
Figure 0007336098000039
前記活性エネルギー線硬化型組成物が、前記ラジカル重合性化合物100質量部に対し、前記一般式(I)で表される化合物を4質量部~20質量部含むことを特徴とする請求項1に記載の活性エネルギー線硬化型組成物。 2. The method according to claim 1, wherein the active energy ray-curable composition contains 4 parts by mass to 20 parts by mass of the compound represented by the general formula (I) with respect to 100 parts by mass of the radically polymerizable compound. The active energy ray-curable composition as described. 前記一般式(I)で表される化合物が、n、mは1以上の整数、n+mは3以上の整数であることを特徴とする請求項1又は2に記載の活性エネルギー線硬化型組成物。 3. The active energy ray-curable composition according to claim 1, wherein n and m are integers of 1 or more and n+m is an integer of 3 or more in the compound represented by the general formula (I). . 前記活性エネルギー線硬化型組成物が、重合開始剤を含むことを特徴とする請求項1乃至3のいずれか1項に記載の活性エネルギー線硬化型組成物。 4. The active energy ray-curable composition according to claim 1, further comprising a polymerization initiator. 前記一般式(I)で表される化合物が、下記の(A-1)~(A-10)、(A-16)で表される構造を有する化合物である請求項1乃至4のいずれか1項に記載の活性エネルギー線硬化型組成物。
Figure 0007336098000040
Figure 0007336098000041
Figure 0007336098000042
Any one of claims 1 to 4, wherein the compound represented by the general formula (I) is a compound having a structure represented by the following (A-1) to (A-10), (A-16) 1. The active energy ray-curable composition according to item 1.
Figure 0007336098000040
Figure 0007336098000041
Figure 0007336098000042
立体造形用材料であることを特徴とする請求項1乃至5のいずれか1項に記載の活性エネルギー線硬化型組成物。 6. The active energy ray-curable composition according to any one of claims 1 to 5, which is a three-dimensional modeling material. 請求項1乃至6のいずれか1項に記載の活性エネルギー線硬化型組成物を用いたことを特徴とする活性エネルギー線硬化型インク組成物。 An active energy ray-curable ink composition comprising the active energy ray-curable composition according to any one of claims 1 to 6. 請求項7に記載の活性エネルギー線硬化型インク組成物を用いたことを特徴とする活性エネルギー線硬化型インクジェット用インク組成物。 An active energy ray-curable inkjet ink composition, comprising the active energy ray-curable ink composition according to claim 7 . 請求項1乃至8のいずれか1項に記載の組成物が収容された組成物収容容器。 A composition container containing the composition according to any one of claims 1 to 8. 請求項1乃至8のいずれか1項に記載の組成物が収容された収容部と、活性エネルギー線を照射するための照射手段とを備えたことを特徴とする2次元または3次元の像形成装置。 9. A two-dimensional or three-dimensional image formation comprising: a container containing the composition according to any one of claims 1 to 8; and irradiation means for irradiating an active energy ray. Device. 請求項1乃至8のいずれか1項に記載の組成物に活性エネルギー線を照射する照射工程を有する、2次元または3次元の像形成方法。 9. A two-dimensional or three-dimensional image forming method, comprising an irradiation step of irradiating the composition according to any one of claims 1 to 8 with an active energy ray. 請求項1乃至8のいずれか1項に記載の組成物の硬化物。 A cured product of the composition according to any one of claims 1 to 8. 基材上に、請求項12に記載の硬化物からなる表面加飾を有することを特徴とする加飾体。 A decorative body comprising a base material and a surface decoration comprising the cured product according to claim 12 on the base material.
JP2019164371A 2019-04-01 2019-09-10 Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable inkjet ink composition, composition container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image Forming method, cured product, and decorative body Active JP7336098B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/837,153 US11920045B2 (en) 2019-04-01 2020-04-01 Active-energy-ray-curable composition, active-energy-ray-curable ink composition, active-energy-ray-curable inkjet ink composition, composition stored container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image forming method, cured material, and decorated article

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019069922 2019-04-01
JP2019069922 2019-04-01

Publications (2)

Publication Number Publication Date
JP2020169310A JP2020169310A (en) 2020-10-15
JP7336098B2 true JP7336098B2 (en) 2023-08-31

Family

ID=72746885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019164371A Active JP7336098B2 (en) 2019-04-01 2019-09-10 Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable inkjet ink composition, composition container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image Forming method, cured product, and decorative body

Country Status (1)

Country Link
JP (1) JP7336098B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3184562A1 (en) 2020-08-19 2022-02-24 Arxada Ag Process for the preparation of phenyl ketones

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013256487A (en) 2011-12-05 2013-12-26 Ricoh Co Ltd (meth)acrylic acid ester, active energy ray-curable composition and ink for inkjet recording
JP2015531809A (en) 2012-10-24 2015-11-05 アグフア−ゲヴエルト Radiation curable ink jet ink
JP2017171726A (en) 2016-03-22 2017-09-28 昭和電工株式会社 Curable composition, cured product thereof, and laminate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013256487A (en) 2011-12-05 2013-12-26 Ricoh Co Ltd (meth)acrylic acid ester, active energy ray-curable composition and ink for inkjet recording
JP2015531809A (en) 2012-10-24 2015-11-05 アグフア−ゲヴエルト Radiation curable ink jet ink
JP2017171726A (en) 2016-03-22 2017-09-28 昭和電工株式会社 Curable composition, cured product thereof, and laminate

Also Published As

Publication number Publication date
JP2020169310A (en) 2020-10-15

Similar Documents

Publication Publication Date Title
EP3033399B1 (en) Ink-jet printing ink comprising n-vinyloxazolidinone
KR20170016458A (en) Ink, ink cartridge, inkjet recording apparatus, printed matter, photopolymerizable compound, photocurable composition, three-dimensional object formation material, and three-dimensional object
JP6900676B2 (en) Active energy ray-curable composition, active energy ray-curable ink, composition container, two-dimensional or three-dimensional image forming device, two-dimensional or three-dimensional image forming method, cured product and decoration
JP2017155132A (en) Active energy ray curable composition, cured article, composition accommodating container, image forming device and image forming method
JP2019163377A (en) Composition, cured product, container, image formation apparatus and image formation method
WO2019071428A1 (en) Compound, photopolymerization initiator, photocurable composition and cured product thereof, and photocurable ink and print using the same
JP2019019309A (en) Composition, cured article, image forming device, and image forming method
JP7336098B2 (en) Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable inkjet ink composition, composition container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image Forming method, cured product, and decorative body
JP6988237B2 (en) UV curable composition, method of forming a two-dimensional or three-dimensional image, cured product, and composition container
JP6775759B2 (en) Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable inkjet ink composition, composition storage container, two-dimensional or three-dimensional image forming apparatus, and two-dimensional or three-dimensional image. Forming method
JP6870201B2 (en) Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable ink composition for inkjet, composition storage container, two-dimensional or three-dimensional image forming apparatus, and two-dimensional or three-dimensional image forming apparatus. Image formation method
JP2016155997A (en) Active energy ray-curable composition, active energy ray-curable ink, composition storage container, apparatus for forming two-dimensional or three-dimensional image, method for forming two-dimensional or three-dimensional image, cured product, decorative body, and active energy ray-polymerizable compound
JP6775758B2 (en) Active energy ray-curable ink, active energy ray-curable inkjet ink, composition container, 2D or 3D image forming device, 2D or 3D image forming method, cured product, and decoration
US11920045B2 (en) Active-energy-ray-curable composition, active-energy-ray-curable ink composition, active-energy-ray-curable inkjet ink composition, composition stored container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image forming method, cured material, and decorated article
JP2019023290A (en) Composition, cured product, storage container, image formation apparatus, and image formation method
JP2013203830A (en) Curable inkjet solventless ink composition
JP2019218447A (en) Active energy ray-curable composition, active energy ray-curable inkjet ink, accommodation container, image forming apparatus and image forming method
JP2006282877A (en) Ink composition, image-forming method using the same and recorded matter obtained using the same
JP7006318B2 (en) Active energy ray-curable ink, active energy ray-curable inkjet ink, composition accommodating container, two-dimensional or three-dimensional image forming apparatus and image forming method, cured product, cured product manufacturing method, and decorative body manufacturing method.
JP6776627B2 (en) Active energy ray-curable composition, active energy ray-curable ink, composition container, image forming apparatus, image forming method, cured product, molded product and compound.
JP6834212B2 (en) Active energy ray-curable composition, active energy ray-curable ink, composition container, two-dimensional or three-dimensional image forming apparatus, image forming method, cured product and structure
JP6825430B2 (en) Active energy ray-curable composition, active energy ray-curable ink, composition storage container, two-dimensional or three-dimensional image forming device, two-dimensional or three-dimensional image forming method, cured product and decoration
JP2018090715A (en) Curable composition, composition container, 2- or 3-dimensional image forming device, 2- or 3-dimensional image forming method, cured product, decoration body, and compound
JP6838269B2 (en) Active energy ray-curable composition, active energy ray-curable ink composition, active energy ray-curable inkjet ink composition, composition storage container, two-dimensional or three-dimensional image forming apparatus, and two-dimensional or three-dimensional image forming apparatus. Image formation method
JP7283294B2 (en) Active energy ray-curable composition, active energy ray-curable ink, active energy ray-curable inkjet ink, container, two-dimensional or three-dimensional image forming apparatus, two-dimensional or three-dimensional image forming method, and cured product manufacturing method

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20190925

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191010

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210716

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220610

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220810

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221111

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230525

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230721

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230809

R150 Certificate of patent or registration of utility model

Ref document number: 7336098

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150